On the heals of several studies warning that NuvaRing contraceptives may increase risks of blood clots, over 1,000 women have filed a NuvaRing lawsuit in a special federal court. Now, a judge has given those who haven’t filed a claim more time to do so.
U.S. District Judge Rodney Sippel, who presides over the NuvaRing cases moved to a Missouri federal court, issued an order on March 8th delaying the start of the first trial until October 21, 2013.
Health experts from the British Medial Journal and New England Journal of Medicine have warned that vaginal ring contraceptives like NuvaRing can have two- to three-times higher risks of blood clots than traditional birth control pills.
Also, the FDA has disclosed receiving over 5,300 reports of complications among women using NuvaRing devices. Most often, these involve pulmonary embolism, thrombosis or deep vein thrombosis. In over 30% of cases, victims actually required hospitalization.
So far, approximately 1,097 NuvaRing lawsuits been consolidated to a special federal court in Missouri. Some others have been filed in New Jersey state court. However, with more than 2,100 complaints to the FDA over blood clots, experts predict many more people have yet to learn about their legal right to seek compensation.
If you or a loved one suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing, it is important to speak with a lawyer about your legal rights as soon as possible. The time to file a claim is limited.
Federal MDL drug injury cases can be very specialized. Therefore, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
Contact us today for more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer.